Toumaz to Exhibit at Embedded World 2011

ToumazToumaz, the leading provider of ultra-low energy wireless telemetry technologies for medical monitoring and internet-connected consumer devices, will be demonstrating its latest ultra-low energy wireless SoC TELRAN at Embedded World 2011 in Germany.

The Embedded World exhibition and conference takes place on 1 - 3 March 2011 at the Exhibition Centre Nürnberg Messe. Embedded World is the World's biggest exhibition of its kind and the meeting place of the international embedded community. The event showcases modern, leading-edge ideas and solutions to global challenges for which engineers and especially the developers of embedded systems bear special responsibility. The accompanying conference is the leading European event for the embedded industry and covers all fields of embedded system development. Toumaz will be exhibiting at the event for the first time and will be located at Stand 367 (Hall 12). On the show floor, attendees will be able to see demonstrations of Toumaz's innovative products, including wireless 3 axis accelerometer using the TZ1053TDK boards at 868MHz.

Toumaz has recently added to its expanding 'Connected Consumer' and Connected Healthcare product portfolio with the launch of TZ1053 TELRAN - an ultra-low energy radio for wireless sensor networks, environmental monitoring and smart metering. The portfolio also includes the SensiumTM vital signs monitoring platform, FENIX DAB+/DAB/FM CMOS RF IC and the XENIF all-in-one internet connected and broadcast audio SoC announced in September 2010.

Embedded World annually attracts 18,350 visitors from 66 countries and continues to grow each year. The event is the top worldwide platform for the industry to exchange ideas and source information at a high level.

Related news articles:

About Toumaz
Toumaz (AIM: TMZ) is pioneering low cost, ultra-low power wireless telemetry technologies for a wide range of markets including medical monitoring and internet-connected consumer devices.

Targeting the healthcare market, Toumaz's licensable smart sensor interface and transceiver platform, Sensium, is a leader in non-intrusive, real-time wireless monitoring of multiple physiological vital signs. Sensium offers the potential to transform medical monitoring and reduce the cost of healthcare by wirelessly connecting individuals to healthcare providers - simply, affordably and unobtrusively. Sensium provides the enabling technology for customers to create complete Body Area Networks based on ultra-low power, ultra-small size body-worn monitors. The Sensium system unlocks new product opportunities across a wide range of healthcare and lifestyle markets, including solutions for hospitals, care homes and telecare settings.

Toumaz also uses its ultra low power expertise to design silicon devices for wireless connectivity and internet-connected consumer products. Toumaz currently supplies FM/DAB radio chips and complete modules to market leaders in the digital radio market.

Toumaz has development centres in Oxford, UK and Taipei City, Taiwan.

Most Popular Now

Stepping Hill Hospital Announced as SPAR…

Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...

AI-Driven Smart Devices to Transform Hea…

AI-powered, internet-connected medical devices have the potential to revolutionise healthcare by enabling early disease detection, real-time patient monitoring, and personalised treatments, a new study suggests. They are already saving lives...